Owens & Minor (OMI) has been under a strong bear grip, hence the stock is down -8.45% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.26% in the past 1 week. The stock has risen by 0.2% in the past week indicating that the buyers are active at lower levels, but the stock is down -5.38% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 2.7% and the 50-Day Moving Average is 3.06%. Owens & Minor Inc. has dropped 1.2% during the last 3-month period . Year-to-Date the stock performance stands at 0.58%.
Owens & Minor (NYSE:OMI): The stock was completely flat for the day, closing at $35.71 on Friday. The flat closing masks the intraday volatility in the stock. After opening at $35.61, the stock touched an intraday high of $35.88 and a low of $35.55. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $35.71. The total trading volume on Friday was 955,642.
Owens & Minor, Inc. is a healthcare logistics company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company operates in two segments: Domestic and International. Domestic segment includes all functions in the United States relating to its role as a healthcare logistics company providing distribution, packaging and logistics services to healthcare providers and manufacturers. International segment consists of its European third-party logistics and packaging businesses. It is focused on its operations on healthcare logistics services and provides its customers with a service portfolio that covers procurement, inventory management, delivery and sourcing of products for the healthcare market. Its customers include hospitals, integrated healthcare systems, group purchasing organizations, manufacturers of life-science and medical devices and supplies, including pharmaceuticals.